Negative C-reactive protein in children with bacterial infection

Pediatrics International

Volumn 41, Issue 5, 1999, Pages 496-499

  Kono, Tatsuo ^a,b   Otsuka, Masahiro ^a   Ito, Masahiro ^a   Misawa, Masahiro ^a   Hoshioka, Akira ^a   Suzuki, Masatoshi ^a   Migita, Takuo ^a   Seki, Ichiro ^a  

^a TOKYO METROPOLITAN BOKUTOH HOSPITAL   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Bacterial infection; C reactive protein; False negative

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; CLINICAL ARTICLE; CLINICAL FEATURE; COXITIS; FEMALE; HUMAN; INFANT; MALE; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; URINARY TRACT INFECTION;

EID: 0032836810     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.1999.01126.x     Document Type: Article

References (17)

1. Richardson C, Emery P. Laboratory markers of disease activity. J Rheumatol. 1996; 23 (Suppl. 44): 23-30.
2. Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr. Infect. Dis. J. 1997; 16: 735-47.
3. Dueholm S, Bagi P, Bud M. Laboratory aid in the diagnosis of acute appendicitis. A blinded, prospective trial concerning diagnostic value of leukocyte count, neutrophil differential count, and C-reactive protein. Dis. Colon Rectum 1989; 32: 855-9.
4. Tejani NR, Chonmaitree T, Rassin DK, Howic VM, Owen MJ, Goldman AS. Use of C-reactive in differentiation between acute bacterial and viral otitis media. Pediatrics 1995; 95: 664-9.
5. Putto A, Meurman O, Ruuskanen O. C-Reactive protein in differentiation of adenoviral, Epstein-Barr viral and streptococcal tonsilitis in children. Eur. J. Pediatr. 1986; 145: 204-6.
6. Jupe D. The acute phase response and laboratory testing. Aust. Fam. Physician 1996; 25: 324-9.
7. Du Clos TW. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens. Mol Biol. Rep. 1996; 23: 253-60.
8. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice. Eur. J. Clin. Invest. 1996; 26: 427-35.
9. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 1994; 15: 81-8.
10. Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE. C-Reactive protein: Structural biology, gene expression, and host defense function. Immunol. Res. 1997; 16: 127-36.
11. Leeuwen MA, van Rijswijk MH. Acute phase proteins in the monitoring of inflammatory disorders. Baillieres Clin. Rheumatol. 1994; 8: 531-52.
12. Mortensen RF. Macrophages and acute-phase proteins. Immunol. Series 1994; 60: 143-58.
13. Shields MJ. A hypothesis resolving the apparently disparate activities of native and altered forms of human C-reactive protein. Immunol. Res. 1993; 12: 37-47.
14. Da Silva O, Ohlsson A, Kenyon C. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: A critical review. Infect. Dis. J. 1995; 14: 362-6.
15. Gerdes JS. Clinicopathologic approach to the diagnosis of neonatal sepsis. Israel J. Med. Sci. 1994; 30: 430-41.
16. Chan DK, Ho LY. Usefulness of C-reactive protein in the diagnosis of neonatal sepsis. Singapore Med. J. 1997; 38: 252-5.
17. Kushner I, Rzewnicki DL. The acute phase response: General aspects. Baillieres Clin. Rheumatol. 1994; 8: 513-30.